Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N2015-01: Neuroblastoma Precision Trial

NCT02868268 is registered in ClinicalTrials.gov with New Approaches to Neuroblastoma Therapy Consortium as lead sponsor.

NCT NCT02868268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02868268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N2015-01: Neuroblastoma Precision Trial
Lead sponsor
New Approaches to Neuroblastoma Therapy Consortium
Phase
Observational
Overall status
Active, not recruiting
Start date
August 22, 2016
Completion date
December 31, 2026
Enrollment
93 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma